Key facts
- This page summarizes Michael Fleck's Form 4 filing for CYREN Ltd..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Jul 2021, 17:29.
Michael Fleck - 21 Jul 2021 Form 4 Insider Report for CYREN Ltd.
- Reporting relationship
- VP Marketing
- Issuer ticker
- N/A
- Reported as of
- 21 Jul 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jul 2021, 17:29:41 UTC
- Prior SEC filing
- 22 Jul 2021
- Next SEC filing
- 28 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Fleck
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Fleck filed Form 4 for CYREN Ltd. on 23 Jul 2021.
Change
- Previous filing in this sequence was filed on 22 Jul 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYRN
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +300,000
- Change %
- +2000%
- Price
- $0.000000
- Shares after
- 315,000
- Date
- 21 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYRN
holding
Derivative
Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 75,000
- Date
- 21 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $1.72
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer under the issuer's 2016 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on July 21, 2022.
Footnote F2
These Options (Right to Buy) vest 25% on August 11, 2021 and then monthly over the next three years.